Global Blood Therapeutics, Inc.
Built from real-time financials, refreshed daily. For a full Analyst Grade with bull/bear case, price targets, and qualitative risk analysis, generate a GBT research report →
About the company
Global Blood Therapeutics, Inc. (GBT) is a biopharmaceutical firm dedicated to discovering, developing, and providing therapies for patients suffering from sickle cell disease (SCD) who currently lack adequate treatment options. Its marketed product, Oxbryta tablets, offers a once-daily, oral treatment for SCD.
- CEO
- Ted Love
- IPO
- 2015
- Employees
- 457
- HQ
- South San Francisco, CA, US
Price Chart
- Market Cap
- $0
- P/E
- -14.21
- P/S
- 0.00
- P/B
- 21.94
- EV/EBITDA
- 0.09
- Div Yield
- 0.00%
- Gross Margin
- 98.30%
- Op Margin
- -147.44%
- Net Margin
- -155.63%
- ROE
- -98.96%
- ROIC
- -33.51%
- Revenue
- $194.75M · 57.31%
- Net Income
- $-303,091,000 · -22.43%
- EPS
- $-4.82 · -19.31%
- Op Income
- $-287,147,000
- FCF YoY
- -17.87%
- 52W High
- $73.02
- 52W Low
- $21.65
- Beta
- 0.46
Get TickerSpark's AI analysis on GBT
Create an account to generate AI analysis on any ticker — technical setup, analyst consensus, earnings watch, insider pulse, financial health, and peer context. Ready in about a minute.
Get Pro Access →Already have an account? Log in
Recent insider transactions
Who's buying, who's selling, and how much.
| Date | Insider | Type | Shares |
|---|---|---|---|
| Oct 5, 22 | PERRY MARK L | sell | 5,600 |
| Oct 5, 22 | PATRICK DEVAL L | sell | 5,600 |
| Oct 5, 22 | Morrison Scott W | sell | 5,600 |
| Oct 5, 22 | Thompson Alexis A. | sell | 3,600 |
| Oct 5, 22 | YARNO WENDY L | sell | 30,000 |
| Oct 5, 22 | Pizzo Philip A. | sell | 7,500 |
| Oct 5, 22 | Svoronos Dawn | sell | 5,600 |
| Oct 5, 22 | PIERCE GLENN | sell | 5,600 |
| Oct 5, 22 | Smith-Whitley Kim | sell | 18,120 |
| Sep 28, 22 | JOHNSON DAVID LEE | other | 22,000 |
Our GBT coverage
Recent articles, reports, and earnings notes.
No research on GBT yet
For a full analyst-grade research report — grades, price targets, financials, chart analysis — generate one on demand.
Generate GBT report →Similar companies
Peers in the same neighborhood.